tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Pasha Sarraf, 5 are a HOLD (38.46%), 7 are a BUY (53.85%), 1 are a SELL (7.69%).
Analyst Pasha Sarraf, carries an average stock price target met ratio of 73.33% that have a potential upside of 82.22% achieved within 609 days. Previously, Pasha Sarraf worked at LEERINK, BAML.
Pasha Sarraf’s has documented 25 price targets and ratings displayed on 6 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on VKTX, Viking Therapeutics at 25-Jun-2025.
Analyst best performing recommendations are on PRVB (PROVENTION BIO).
The best stock recommendation documented was for ACRS (ACLARIS THERAPEUTICS) at 3/4/2021. The price target of $26 was fulfilled within 15 days with a profit of $4.86 (22.99%) receiving and performance score of 15.33.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 05-May-2026
$11
$6.61 (150.57%)
$6
5 months 3 days ago
(05-May-2026)
1/2 (50%)
$6.25 (131.58%)
391
Buy Since 29-Nov-2016
$12
$7.61 (173.35%)
5 months 3 days ago
(05-May-2026)
0/2 (0%)
$7.25 (152.63%)
Buy Since 28-May-2025
$10
$5.61 (127.79%)
$8
5 months 9 days ago
(29-Apr-2026)
0/3 (0%)
$5.53 (123.71%)
Buy Since 14-May-2025
$16
$11 (220.00%)
$16
6 months 19 days ago
(19-Mar-2026)
0/11 (0%)
$12.26 (327.81%)
Buy Since 09-May-2025
$9
$4.61 (105.01%)
1 years 4 months 29 days ago
(09-May-2025)
1/12 (8.33%)
$7.74 (614.29%)
611
